STOCK TITAN

Gilead Sciences (GILD) S-3 Filings

GILD NASDAQ

Here are the S-3 shelf registrations from Gilead Sciences Inc (GILD) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

An S-3 covers the shelf registration that lets an established company sell over time, so if you follow GILD and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full GILD filings page.

Rhea-AI Summary

Gilead Sciences, Inc. has filed an automatic shelf registration statement on Form S-3, allowing it to offer from time to time a broad range of securities, including senior debt, common stock, preferred stock, depositary shares, warrants, subscription rights, stock purchase contracts and stock purchase units. Specific amounts, prices and terms for each issuance will be set in future prospectus supplements.

The company’s common stock is listed on the Nasdaq Global Select Market under the symbol GILD. Authorized capital consists of 5,600,000,000 shares of common stock and 5,000,000 shares of preferred stock, with the board empowered to set the rights of any preferred series. Net proceeds from offerings under this shelf may be used for general corporate purposes.

The filing summarizes key terms of potential senior debt securities, including ranking as unsecured obligations, covenants limiting certain liens and sale-leaseback transactions (subject to a 15% consolidated net tangible asset basket), and merger and defeasance provisions under a New York law–governed indenture. It also highlights anti-takeover and exclusive-forum features in Gilead’s charter and bylaws and incorporates by reference its most recent 10-K, 10-Qs and 8-Ks for detailed financial and risk information.